Amarin Corp Plc (AMRN)

[picasel]

Fish, I think, it certainly would be the most advantageous time to again go after the FDA for the rescinded SPA. New science abounds, as well as a new head that is a cardiologist who may understand the science better. In my view continuing the fight through the hierarchy of the FDA would both demonstrate our willingness to correct a wrong with them first and not present ourselves as a hostile enemy (as they implied in the 1st A suit) and like wise show ourselves as a tenacious company who just may take legal action against them again if they get it wrong again. And as Woodcock has said "come to us first". A thoughtful successful action here would open the floodgates and may only take another focused effort.